In Biotech, Bluebird Bio, Column, Fundings & Exits, Impact Biomedicines, initial public offering, Inogen, Juno Therapeutics, Kythera Biopharmaceuticals, Receptos, Sage Therapeutics, TC, TechCrunch - Funding & Exits, Technology News
Posted Home run exits happen stealthily for biotech
Joanna Glasner Contributor More posts by this contributor While tech waffles on going public, biotech IPOs boom Shoe startups aren’t dragging their feet Startup exit tallies commonly [...]